Cologne, Germany

Jürgen Rawert

This inventor holds 15 USPTO granted patents and 7 published patent applications and 24 EPO patents. Top assignees: Softhale Nv, Invox Belgium Nv. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jürgen Rawert. Retrieved from https://idiyas.com/inventor/jürgen-rawert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.9

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Jürgen Rawert - Innovator in Respiratory Treatment

Introduction

Jürgen Rawert is an inventor based in Köln, Germany. He has made significant contributions to the field of respiratory treatment through his innovative approaches. Although he currently holds no granted patents, his work is focused on developing methods for treating viral infections and respiratory diseases.

Latest Patent Applications

Jürgen Rawert's latest patent applications include:

1. **Methods of Treatment Using Niclosamide** - This invention provides a method for treating respiratory diseases or viral infections by administering a medically active liquid in nebulized form. The liquid comprises niclosamide or a pharmaceutically acceptable salt, which is delivered using an inhalation device.

2. **Method for the Treatment of Viral Infections** - This application outlines a method for treating respiratory conditions resulting from viral infections. It involves administering a medically active liquid that includes an inhalable corticosteroid, also delivered in nebulized form via an inhalation device.

Conclusion

Jürgen Rawert's innovative work in respiratory treatment showcases his commitment to advancing medical solutions for viral infections and respiratory diseases. His latest patent applications reflect his dedication to improving patient care through effective treatment methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…